Challenges and Strategies for Improving Access to Cancer Drugs in Malaysia: Summary of Opinions Expressed at the 2nd MACR International Scientific Conference 2022.
Journal Information
Full Title: Cancer Manag Res
Abbreviation: Cancer Manag Res
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Disclosure Muthukkumaran Thiagarajan is the current President and the past Honorary Secretary of the Malaysian Oncological Society. He has received honorarium payments for lectures, presentations and educational events from Norvatis, Roche, Astra Zeneca, Merk, Boehringer Ingelheim, Ipsen, Eisai, Eli Lilly, Pfizer TaiHo and Astellas. The authors report no other conflicts of interest in this work."
Funding Disclosure
Evidence found in paper:
"Funding and Regulation"
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025